Contact us
Young GI
Patients
Industry
Press
My Connect
Create myUEG account
About
To landing page
Who we are
Boards, Committees & Groups
Governance
Headquarters Management
History
What we do
Strategic Drivers
Year in Review
Our Members
Specialist Member Societies
National Member Societies
myUEG Community
myUEG Associates
My Connect
Women in GI
Young GIs
Researchers
Event Calendar
Week
To landing page
Programme
Postgraduate Teaching
Industry
Supporters
CME Accreditation
UEG Week on-demand
Future UEG Weeks
Education
To landing page
Online Education
Online Courses
Webinars
Career Development
Face-to-face Education
Summer School
Masterclass
Clinical Visiting Fellowships
Education Resources
Mistakes in...
UEG Talks Podcast
Image Hub
CME in Europe
Event Endorsement
Supporters
Research
To landing page
Support
Horizon Europe Support
Start-up Grant
Research Prize
Research Fellowship
Research Webinars
Research Projects
HoloSurge
Position Papers
White Book 2
Main Results
Full Reports
Materials and Presentations
Quality of Care
To landing page
Search Guidelines
Standards & Guidelines Repository
Non-English Guidelines
GI Guidelines App
Develop & Implement
How to develop guidelines
Guideline Endorsement
Guideline Webinars
Projects
Quality of Care Initiatives
Quality Standards
Public Affairs
To landing page
Advocacy
Core Positions
Stakeholder Collaboration
White Book 2
Position Papers
MEP Digestive Health Group
Our Supporters
#EUNewsline →
EU Elections 2024
Publications
To landing page
Publications
Congress Publications
Research Publications
Public Affairs Publications
Education Publications
UEG Publications
UEG Journal →
UEG Journal Podcast
White Book 2
Opportunities
To landing page
Congress Opportunities
Top Abstract Prizes
National Scholar Award
Travel Grants
International Scholarship Awards
Research Funding
Research Prize
Research Fellowship
Horizon Europe Support
Start-up Grant
Activities Funding
Recognition of Achievements
Lifetime Achievement Award
Journal Best Paper Award
Activities Endorsement
Professional Advancement
Rising Star Awards
Clinical Visiting Fellowships
Open Positions
Talent Pool
Library
To landing page
Congress Resources
UEG Week on-demand
Abstracts
Posters
Guideline Resources
Education Resources
Image Hub
Webinars
Mistakes in... articles
Contact us
Young GI
Patients
Industry
Press
Session
PP 05 IBD (Posters)
EXAMINING MENTAL HEALTH DISEASE BURDEN AMONG CROHN’S DISEASE (CD) PATIENTS IN EUROPE
PP 05 IBD (Posters)
et al.
IMMUNOLOGICAL EFFECTS OF HEPATITIS B VIRUS VACCINATION IN INFLAMMATORY BOWEL DISEASE PATIENTS
PP 05 IBD (Posters)
et al.
NEOPLASIA CHARACTERISATION IN IBD COLON: AN INTERNATIONAL MULTI-CENTRE STUDY OF ENDOSCOPIST PERFORMANCE AND A GENERIC COLON CADX ALGORITHM PERFORMANCE
PP 05 IBD (Posters)
et al.
TARGETING IMPROVED TREG SELECTIVITY WITH THE IL-2 MUTEIN EFAVALEUKIN ALFA: RATIONALE FOR IL-2 THERAPY IN ULCERATIVE COLITIS
PP 05 IBD (Posters)
et al.
INVESTIGATING THE EVOLUTION OF THE TREATMENT ALGORITHM OF ULCERATIVE COLITIS PATIENTS
PP 05 IBD (Posters)
et al.
THE LONG-TERM EFFECT ON SURGERY-FREE SURVIVAL OF BIOLOGICAL COMPARED TO CONVENTIONAL THERAPY IN CROHN’S DISEASE IN REAL WORLD-DATA: A PROPENSITY-SCORE MATCHED STUDY
PP 05 IBD (Posters)
et al.
CELL WALL DEFICIENT (CWD) MYCOBACTERIA IN WBCS AND ILEAL CROHN’S TISSUES
PP 05 IBD (Posters)
et al.
THE PROBIOTIC SACCHAROMYCES BOULARDII CNCM I-745 PRESERVES AND RESTORES THE FUNCTIONALITY OF THE INTESTINAL BRUSH BORDER UPON INFLAMMATION
PP 05 IBD (Posters)
et al.
CADE-IBD: A REALITY OR A DREAM? PROSPECTIVE EVALUATION OF A NOVEL NEURAL NETWORK FOR DETECTION OF NEOPLASIA IN IBD COLON
PP 05 IBD (Posters)
et al.
EFFECTS OF ANTI-TNF AND ANTI-INTERLEUKINS 12 AND 23 DRUGS ON CIRCULATING DENDRITIC CELLS MIGRATORY CAPACITY IN INFLAMMATORY BOWEL DISEASE
PP 05 IBD (Posters)
et al.
CLINICAL FACTORS ASSOCIATED WITH NAFLD IN IBD PATIENTS AND COMPARISON BETWEEN PATIENTS WITH NAFLD EXCLUSIVELY
PP 05 IBD (Posters)
et al.
URINARY LITHOGENIC PROFILE AND GUT AND URINARY MICROBIOTA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
PP 05 IBD (Posters)
et al.
INCIDENCE, EVOLUTION OF DISEASE PHENOTYPE, TIME TO BIOLOGICAL THERAPY AND MEDIUM-, LONG-TERM SURGERY RATES IN IBD-U PATIENTS IN WESTERN HUNGARY – A POPULATION-BASED STUDY BETWEEN 1977–2020, DATA FROM THE VESZPREM COUNTY COHORT
PP 05 IBD (Posters)
et al.
DECLINING TRENDS OF REOPERATIONS AND DISEASE BEHAVIOR PROGRESSION BUT NOT FIRST RESECTIVE SURGERY IN CROHN’S DISEASE OVER DIFFERENT THERAPEUTIC ERAS – A PROSPECTIVE POPULATION-BASED STUDY FROM WESTERN HUNGARY BETWEEN 1977–2020, DATA FROM THE VESZPREM COHO
PP 05 IBD (Posters)
et al.
DERMAL LESIONS ASSOCIATED WITH ANTI-TUMOR NECROSIS FACTOR THERAPY IN PATIENTS WITH INFLAMMATORY BOEWL DISEASES: INSIGHTS FROM A IBD TERTIARY CENTER IN POLAND - A SINGLE-CENTER, RETROSPECTIVE STUDY
PP 05 IBD (Posters)
et al.
PLATELET ACTIVATION AND PLATELET-MONOCYTE INTERACTIONS CORRELATE WITH MUCOSAL INFLAMMATION AND DISEASE SEVERITY IN ULCERATIVE COLITIS
PP 05 IBD (Posters)
et al.
FAECAL CALPROTECTIN IS A NON-SPECIFIC MARKER OF INFLAMMATION IN ADULTS OVER THE AGE OF 50
PP 05 IBD (Posters)
et al.
BURDEN OF PERIANAL DISEASE AND PERIANAL SURGERY IN CROHN’S DISEASE OVER DIFFERENT THERAPEUTIC ERAS – A POPULATION-BASED STUDY FROM WESTERN HUNGARY BETWEEN 1977–2020, DATA FROM THE VESZPREM COUNTY COHORT
PP 05 IBD (Posters)
et al.
BIOMARKER OF CORTICOSTEROID THERAPY FOR MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
PP 05 IBD (Posters)
et al.
REAL-WORLD STUDY ON VEDOLIZUMAB EFFICACY AND SAFETY AFTER THE TRANSITION FROM INTRAVENOUS TO SUBCUTANEOUS VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE PATIENTS
PP 05 IBD (Posters)
et al.
Item 281 - 300 / 826
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
Chat with us
, powered by
LiveChat